Einstein Experts for Media
Molecular and Cell Biology
Ana Maria Cuervo, Ph.D., M.D.
Professor, Developmental and Molecular Biology
Professor, Anatomy and Structural Biology
Co-Director, Institute for Aging Research
Robert and Renée Belfer Chair for the Study of Neurodegenerative Diseases
Molecular BiologyAgingAutophagy
Cellular biology
Dr. Cuervo is considered a leader in the field of autophagy— the process by which cells remove and recycle their waste. The Barcelona, Spain native is also an expert on the cellular biology of aging. Dr. Cuervo has been quoted in numerous publications, including The New York Times, Nature, Science, Scientific American, and The Scientist. read more...
Robert H. Singer, Ph.D.
Professor and Co-chair, Anatomy & Structural Biology
Co-director, Gruss Lipper Biophotonics Center
Professor, Dominick P. Purpura Department of Neuroscience
Professor, Cell Biology
Harold and Muriel Block Chair in Anatomy & Structural Biology
Single-cell imagingmRNABiophotonics
Dr. Singer is a leader in the field of biophotonics, which enables scientists to observe activities within living cells at the molecular level, and in the study of mRNA, a molecule that controls the expression and positioning of proteins within cells. Dr. Singer, who was called a “pioneer” by Science magazine, leads a robust lab that focuses on how RNA is expressed by the genome and how it travels from the site of its birth to its ultimate location in the cell where it makes proteins. read more...
Ulrich G. Steidl, Ph.D., M.D.
Professor, Cell Biology
Professor, Medicine
Deputy Director, Montefiore Einstein Comprehensive Cancer Center
Rose C. Falkenstein Chair in Cancer Research
Interim Director, The Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research
Leukemias and myelodysplastic syndromes Pre-cancerous and cancer stem cellsCell and tumor biology
Dr. Steidl studies the molecular and cellular mechanisms that lead to two related blood diseases, myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). His NIH-funded basic and translational research seeks to define the characteristics of pre-leukemic stem cells (pre-LSC), understand their progression to leukemic stems cells, and develop drug strategies to target the process. Dr. Steidl is co-director of the Montefiore Einstein Comprehensive Cancer Center's Blood Cancer Institute. read more...